The age-related macular degeneration market is witnessing significant growth, driven by the rising geriatric population, increasing prevalence of retinal disorders, and advancements in ophthalmic drug development. Valued at USD 10.46 billion in 2024, the market is projected to reach USD 26.40 billion by 2034, expanding at a CAGR of 9.70% during the forecast period (2025–2034).
Age-Related...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt